TriSalus Life Sciences Statistics
Total Valuation
TLSI has a market cap or net worth of $173.30 million. The enterprise value is $193.42 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSI has 32.27 million shares outstanding. The number of shares has increased by 138.12% in one year.
| Current Share Class | 32.27M |
| Shares Outstanding | 32.27M |
| Shares Change (YoY) | +138.12% |
| Shares Change (QoQ) | +3.54% |
| Owned by Insiders (%) | 20.75% |
| Owned by Institutions (%) | 44.30% |
| Float | 25.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.45 |
| Forward PS | 4.76 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.57 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -85.52% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -188.61% |
| Revenue Per Employee | $292,191 |
| Profits Per Employee | -$275,573 |
| Employee Count | 110 |
| Asset Turnover | 1.38 |
| Inventory Turnover | 1.31 |
Taxes
In the past 12 months, TLSI has paid $8,000 in taxes.
| Income Tax | 8,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.19% in the last 52 weeks. The beta is 0.50, so TLSI's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -46.19% |
| 50-Day Moving Average | 5.38 |
| 200-Day Moving Average | 4.95 |
| Relative Strength Index (RSI) | 53.61 |
| Average Volume (20 Days) | 32,934 |
Short Selling Information
The latest short interest is 35,555, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 35,555 |
| Short Previous Month | 26,379 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.14% |
| Short Ratio (days to cover) | 0.89 |
Income Statement
In the last 12 months, TLSI had revenue of $32.14 million and -$30.31 million in losses. Loss per share was -$1.14.
| Revenue | 32.14M |
| Gross Profit | 27.51M |
| Operating Income | -31.82M |
| Pretax Income | -63.97M |
| Net Income | -30.31M |
| EBITDA | -31.08M |
| EBIT | -31.82M |
| Loss Per Share | -$1.14 |
Full Income StatementBalance Sheet
The company has $13.00 million in cash and $33.12 million in debt, giving a net cash position of -$20.12 million or -$0.62 per share.
| Cash & Cash Equivalents | 13.00M |
| Total Debt | 33.12M |
| Net Cash | -20.12M |
| Net Cash Per Share | -$0.62 |
| Equity (Book Value) | -34.37M |
| Book Value Per Share | -1.06 |
| Working Capital | 13.34M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 85.60%, with operating and profit margins of -99.01% and -84.67%.
| Gross Margin | 85.60% |
| Operating Margin | -99.01% |
| Pretax Margin | -84.65% |
| Profit Margin | -84.67% |
| EBITDA Margin | -96.70% |
| EBIT Margin | -99.01% |
| FCF Margin | n/a |